1425 related articles for article (PubMed ID: 12881481)
1. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
2. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.
Kou B; Vatish M; Singer DR
Vascul Pharmacol; 2007 Oct; 47(4):199-208. PubMed ID: 17804301
[TBL] [Abstract][Full Text] [Related]
4. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF.
Amaral SL; Linderman JR; Morse MM; Greene AS
Microcirculation; 2001 Feb; 8(1):57-67. PubMed ID: 11296854
[TBL] [Abstract][Full Text] [Related]
6. The angiotensin II type 2 receptor primarily inhibits cell growth via pertussis toxin-sensitive G proteins.
Ozawa Y; Suzuki Y; Murakami K; Miyazaki H
Biochem Biophys Res Commun; 1996 Nov; 228(2):328-33. PubMed ID: 8920914
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
8. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.
Liu HW; Cheng B; Yu WL; Sun RX; Zeng D; Wang J; Liao YX; Fu XB
Life Sci; 2006 Jun; 79(5):475-83. PubMed ID: 16522324
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
[TBL] [Abstract][Full Text] [Related]
11. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
12. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
13. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
Schelman WR; Andres R; Ferguson P; Orr B; Kang E; Weyhenmeyer JA
Brain Res Mol Brain Res; 2004 Sep; 128(1):20-9. PubMed ID: 15337314
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
[TBL] [Abstract][Full Text] [Related]
17. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
19. Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells.
Weidekamm C; Hauser P; Hansmann C; Schwarz C; Klingler H; Mayer G; Oberbauer R
Wien Klin Wochenschr; 2002 Aug; 114(15-16):725-9. PubMed ID: 12602118
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
